In the News
Synexus launches new patient registry to support longitudinal brain aging study
Dawie Wessels explains that Synexus is looking to register 30,000 adults for the five-year study focused on identifying potential prevention methods and possible treatments for Alzheimer’s and other dementias.
Synexus debuts new patient registry in U.S. for study of longitudinal brain aging
Synexus is collaborating with the University of Exeter in the U.K. to launch a registry-based study in the U.S. to better understand how healthy brains age.
PPD updates central lab tech, launches new app for investigator portal
Christopher Fikry explains how the over-arching purpose of the enhancements will improve the user experience for the company’s clients and investigative sites.
Emerging Technology Integration in FDA’s Drug Approval Process
Monika Jain and Shilpa Rana discuss the FDA’s “Emerging Technology Program.”
Brazil’s Regulatory Environment Offers Positive Changes for Clinical Trials
Priscila Fagundes, Patricia Dresel and Ana Elisa Miller summarize recent changes in regulations and submission processes in Brazil’s approach to conducting clinical trials.
A Study of the Effects of Histogram Binning on the Accuracy and Precision of Particle Sizing Measurements
Eric Olson analyzes the effectiveness of histogram binning for representing particle-sizing measurements with accuracy and precision.
The outsourcing balancing act
Leona Fitzgerald and Denise Moody talk about achieving the best balance of oversight and involvement.
PPD: Meeting biopharma demand is a ‘substantial undertaking’ for CRO industry
In this article and video, Jon Denissen discusses how PPD Laboratories is keeping up with the demand for biopharmaceuticals.
Biopharma business booming in Middleton
PPD® Laboratories has been expanding its operations in Middleton over the past few years, increasing its highly scientific workforce by 50 percent during that time.
